Last reviewed: June 20, 2026
Last updated: June 20, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a leading medication for weight loss with clinical trials showing average weight reductions of 15% over 68 weeks. Understanding how dosing works—and why starting low matters—helps patients achieve sustainable results without overwhelming side effects. PlexusDx provides compounded semaglutide from licensed 503A pharmacies, allowing flexible dosing tailored to individual tolerance and metabolic needs.
How Semaglutide Dosing Typically Begins
Most weight loss protocols with semaglutide begin at a low starting dose of 0.25 mg once weekly, injected subcutaneously into the abdomen, thigh, or upper arm. This conservative entry point allows the body to adjust to the medication's appetite-suppressing effects while the gastrointestinal system acclimate to reduced food intake. Starting low also minimizes nausea and vomiting, which affect roughly 30–50% of patients during the first few weeks if dosing escalates too quickly.
The standard titration schedule increases by 0.25 mg every one to four weeks, depending on tolerability and individual response. By week 4, patients typically reach 0.5 mg weekly; by week 8, they may move to 0.75 mg; and by week 12, many reach a maintenance dose of 1.0 mg per week. However, some individuals respond optimally at lower doses—0.5 or 0.75 mg weekly—while others benefit from doses up to 2.4 mg weekly, the highest approved strength.
Why Gradual Titration Improves Long-Term Success
Rushing through dose increases can trigger severe nausea, constipation, and appetite suppression so pronounced that patients struggle to eat adequate protein and micronutrients. A slow, methodical titration allows appetite reduction to occur alongside behavioral adjustments—meal planning, portion control, and protein prioritization—so weight loss becomes sustainable rather than crisis-driven. Research published in the New England Journal of Medicine found that patients who titrated slowly reported better medication adherence and fewer discontinuations due to side effects.
Gradual dosing also gives clinicians time to monitor individual metabolic markers, hunger signals, and side effect patterns. Some patients plateau at 0.5 mg and maintain steady weight loss without escalating further, while others require 1.5–2.0 mg to see meaningful results. Genetic variations in GLP-1 receptor sensitivity—assessed through PlexusDx's Precision Peptide Genetic Test—can influence how quickly and at what dose a patient responds, making personalized dosing far more effective than one-size-fits-all protocols.
Compounded Semaglutide vs. Branded Wegovy: Dosing Flexibility
Branded Wegovy comes in pre-filled pens at fixed strengths: 0.25, 0.5, 0.75, 1.0, 1.7, and 2.4 mg per dose. While convenient, this system locks patients into specific increment sizes and can make fine-tuning difficult if a patient needs 0.3 mg, 0.6 mg, or 1.2 mg to optimize their response. Compounded semaglutide from licensed 503A pharmacies, like those supplying PlexusDx, offers dosing flexibility that branded options cannot match.
PlexusDx compounded semaglutide injections start at $149 per month and maintain that flat monthly price regardless of dose adjustments. This means a patient can work with their provider to find the precise dose that works best—whether that is 0.4 mg, 1.1 mg, or 1.9 mg weekly—without penalty or price escalation. The flexibility to adjust doses in smaller increments often leads to better side effect management and faster identification of each patient's optimal therapeutic dose, improving adherence and outcomes.
Factors That Influence Your Optimal Semaglutide Dose
Body weight, baseline metabolic rate, kidney function, and prior medications all influence the dose at which semaglutide becomes effective. Patients with higher starting weights or severe insulin resistance may require higher doses to suppress appetite adequately, while those with normal kidney function and stable blood sugar may achieve results at moderate doses. Age, sex, and previous weight loss attempts also play a role: older patients or those with a long history of weight cycling may respond more slowly and require upward titration.
Genetic factors encoded in your peptide pathways—such as GLP-1 receptor sensitivity, GIPR signaling, and FTO metabolic predisposition—significantly affect how your body processes and responds to semaglutide. PlexusDx's Precision Peptide Genetic Test ($99 add-on after the first month of treatment) maps 14 pathways, 49 peptides, and over 150 genetic insights, including key variants like GLP1R rs6923761, to predict which patients will respond robustly to standard doses versus those who may need higher or lower titration schedules. This precision-medicine approach removes guesswork and accelerates the path to your ideal dose.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is a typical starting dose of semaglutide for weight loss?
Most weight loss programs with semaglutide begin at 0.25 mg injected once weekly. This low starting dose minimizes nausea and allows your body to adjust before increasing by 0.25 mg increments every 1–4 weeks. PlexusDx compounded semaglutide starts at $149/month and supports flexible titration at any dose strength.
How long does it take to reach an effective dose?
Patients typically reach a maintenance dose of 1.0–1.5 mg weekly within 12–16 weeks of gradual titration. However, response timelines vary: some people see weight loss at 0.5 mg, while others require 2.0 mg or higher. Your provider may adjust your timeline based on side effects, weight loss progress, and lab results.
Can I adjust my semaglutide dose if I'm not seeing results?
Yes. If you reach your current dose and weight loss plateaus, your provider may increase the dose by 0.25 mg weekly. With PlexusDx compounded semaglutide, dose adjustments occur at the same flat $149/month price—your dose may go up, but your price won't.
What are common side effects at higher semaglutide doses?
At doses above 1.0 mg weekly, nausea, constipation, and reduced appetite become more pronounced in some patients, though these typically subside after a few days. Vomiting and stomach pain occur in fewer than 10% of patients if dosing is titrated slowly. Staying hydrated, eating protein-rich foods, and adjusting meal timing can minimize discomfort.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test analyzes your GLP-1 receptor sensitivity, GIPR signaling capacity, and metabolic variants to predict whether you'll respond best to low, moderate, or higher semaglutide doses. This precision insight, added for $99 after your first month of treatment, helps your provider avoid unnecessary dose escalation or under-dosing, accelerating your path to weight loss success.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Do You Gain After Stopping Wegovy?
Navigating Your Journey: How Does a Wegovy Pen Work for Effective Weight Loss?